Company intelligence / Profile preview

Jiuzhitang Co., Ltd.

Ownership: Private
Employees: ~3519
Development stage: Commercial

Overview

The company has over 300 products across various therapeutic areas including cardiovascular treatment, dermatology, and digestants. It has also conducted clinical trials for stem cell treatments through partnerships

Therapeutic areas: GastroenterologyPulmonologyCardiovascularNephrologyRheumatologyDermatologyOtherWomen's HealthNeurology
Modalities: Traditional Chinese medicinechemical medicinebiological medicinestem cell drugs
Industry: Pharma

Drug pipeline

4 assets

human bone marrow mesenchymal stem cells (Jiuzhitang Maker)

3 more assets in the full pipeline.

Request access →

Partnerships

Stemedica (for stem cell clinical trials)

Beyond the preview

Go deeper on Jiuzhitang Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiuzhitang Co., Ltd..

Explore the full profile